Public Health

$3.5 million HRSA award to Children’s National strengthens leadership and care for children with developmental disabilities

Children with autism painting

The program prepares future leaders to improve the health and well-being of children and youth with autism and other neurodevelopmental disabilities, and the well-being of their families.

Children’s National received a five-year, $3.5 million competitive funding renewal from the Health Resources and Services Administration (HRSA) for its Leadership Education in Neurodevelopmental and Related Disabilities (LEND-CN) program.

What it means

The program prepares future leaders to improve the health and well-being of children and youth with autism and other neurodevelopmental disabilities, and the well-being of their families. LEND-CN brings together emerging professionals from 14 disciplines, family members and self-advocates, with a goal to develop leaders who can deliver coordinated care, strengthen access to services and strengthen support systems.

Training combines faculty mentorship, clinical and community experiences, leadership education, policy and advocacy activities, and collaborative projects. Family members and people with disabilities participate as both trainees and faculty to embed lived experience directly into learning.

LEND-CN co-directors Mark L. Batshaw, MD, a developmental pediatrician, and Anne P. Inge, PhD, a clinical psychologist, note that, “By investing in the people who provide care and including those who receive it as partners in leadership development the award supports a stronger workforce and builds more responsive services for children and their families”.

Why it matters

Families navigating life with a child or adolescent who has developmental disabilities often need services that span healthcare, education and community settings. Shortages of trained professionals and fragmented referral pathways can make that care difficult to obtain.

LEND-CN addresses these challenges, teaching participants to work across disciplines and partner with families to identify needs and develop solutions.

What’s next

The renewal expands on the program’s demonstrated workforce contributions. According to alumni follow-up findings, 88% of LEND-CN alumni continue to work with people with autism or other developmental disabilities. In addition, 69% supervise, educate or train others and 38% report developing new programs or services.

For the next five years, LEND-CN will continue preparing interdisciplinary leaders while also providing continuing education and technical assistance to professionals, educators and community partners. The program emphasizes evidence-based practice, family- and person-centered care and improving access for underserved communities.

Children’s National leads the way

Children’s National leads the program in partnership with Howard University, the University of the District of Columbia, George Washington University, Gallaudet University and The Catholic University of America. The program’s collaborations connect expertise across disciplines and strengthen workforce development across Washington, D.C., Maryland and Virginia.

Podcast: Kids First: Strengthening the Workforce Behind Pediatric Care

Children’s National at the 2026 American Academy of Pediatrics meeting

American Academy of Pediatrics National Conference & Exhibition, taking place in San Diego, California, from October 2-6.Children’s National experts will participate in this year’s American Academy of Pediatrics National Conference & Exhibition, taking place in San Diego, California, from October 2-6. Below is a schedule of sessions led by professionals from Children’s National:

Lanre Falusi, MD, MEd, FAAP, pediatrician and medical director of Advocacy Education
H3015: Joint Program: Council on Health Equity and Council on Community Pediatrics
Advocacy and Civic Engagement to Advance Child Health

Sunday, October 4
8:00 AM – 12:00 PM PDT

Rana F. Hamdy, MD, MPH, MSCE, infectious diseases specialist and medical director of the Antimicrobial Stewardship Program 
S1326: Faringitis por estreptococo del grupo A: ¿estamos diagnosticando y tratando apropiadamente?
Friday, October 2, 2026
1:00 PM – 2:00 PM PDT
S1522: Group A Streptococcal Pharyngitis—Are We Testing and Treating Appropriately?
Friday, October 2, 2026
4:00 PM – 5:00 PM PDT

Jessica Nash, MD, IBCLC, pediatrician and associate medical director, Children’s National Anacostia  
S4421: Breastfeeding Essentials
Monday, October 5, 2026
3:30 PM – 4:30 PM PDT

Vasum Peiris, MD, MPH, FAAP, FACC, FASE, advanced imaging cardiologist
S2520: Advocating for Pediatric Innovation: Where We’ve Been and Where We’re Going
Saturday, October 3, 2026
5:00 PM – 6:00 PM PDT
H3016: Joint Program: Section on Innovation in Therapeutics and Technology, Section on Telehealth Care, and Council on Clinical Information Technology
Digital Health is Already Here: Preparing Pediatricians for the Next Era of Care

Sunday, October 4, 2026
8:00 AM – 12:00 PM PDT

Dennis Ren, MD, MEd, pediatric emergency medicine physician
H2021: Section on Emergency Medicine Annual Meeting: Day 2
PEM Hot Topic, EmergiQuiz, PEMPix, and State of the Section Awards

Saturday, October 3, 2026
8:00 AM – 5:00 PM PDT

Gisella Valderrama, MD, MEd, emergency medicine physician
W1502: When a Meal Train is Not Enough: Supporting Academic Physicians through Serious Illness
Friday, October 2, 2026
3:30 PM – 5:00 PM PDT

Jessica Weisz, MD, MBA, pediatrician
H2010: Joint Program: Council on School Health, Council on Children with Disabilities and Council on Community Pediatrics
Saturday, October 3, 2026
8:00 AM – 12:00 PM PDT

To view the full schedule along with options to join sessions virtually, please visit the AAP conference website.

Nurse-led outreach re-engages cardiac surgery patients lost to follow-up

boy undergoing electrocardiogram test in clinic

The study demonstrated that a dedicated system of outreach to those lost to care can be leveraged to bring some people back into routine assessment.

A single center study at Children’s National analyzed more than 1,500  patient records from the last 33 years and found 16% of patients in that time range had not been seen by a cardiologist in at least 18 months and considered “lost to follow-up” after cardiac surgery.

However, a cardiac nurse-led outreach program successfully re-connected with more than a third of them to schedule follow up appointments. Through these interactions they also offered health education about the critical nature of follow-up and helped resolve barriers that previously kept people from seeking follow-up care. The study was published in the European Journal of Cardiovascular Nursing.

What it means

Despite more successful surgical repairs and treatments available than ever, congenital heart disease (CHD) remains a lifelong diagnosis that requires continual care to assess for and intervene when there is a life-threatening issue.

The authors initially reviewed the records of 1,555 patients who underwent surgical repairs for congenital heart disease categorized as benchmark procedures  by the Society of Thoracic Surgery Congenital Heart Surgery Database, including repairs of aortic arch anomalies, tetralogy of Fallot (TOF), atrioventricular septal defect (AVSD), transposition of the great arteries (TGA) and Fontan palliation at Children’s National. They found 254 patients (16%)were lost to follow up at this one institution.

However, the study demonstrated that a dedicated system of outreach to those lost to care can be leveraged to bring some people back into routine assessment. A program led by a nurse with significant experience in congenital heart disease and its repair succeeded in reaching 158 (62%) of the lost group. The nurse sought to remove barriers to follow-up and guide people back to the appropriate care provider. More than 90 people (37%) agreed to schedule follow-up appointments, with 57 of them completing cardiology appointments at Children’s National.

Why it matters

There is significant research showing that the risks of premature morbidity and mortality in people with congenital heart disease increase when there is no routine follow up by a cardiac specialist.

Over time, those who are lost to follow-up are more likely to experience an emergent issue requiring urgent intervention. Unfortunately, many families struggle with maintaining lifelong, routine cardiology appointments. It is important for care providers to understand the external factors that may play a role in whether they continue follow-up. At Children’s National, the study identified distance, insurance issues and a perception of overall wellness as factors impacting the likelihood of attending follow-up visits. Transportation, scheduling conflicts and health literacy levels also played a role.

Children’s National leads the way

In this study, the team designed a pilot, nurse-led program aimed at drawing in some of those previously lost to care. Feedback from those who were reached helped the center make immediate process changes for current patients, to help prevent future loss. For example:

  • Appointment no-shows or cancellations are now tracked and reported monthly so a designated outreach coordinator can proactively contact families to reschedule and address any barriers.
  • The outreach coordinator also places follow-up orders for future visits within the medical record for patients based on their last follow-up note.

“We have begun to shift the mental burden of follow-up to the health care system…These small practice changes can ensure long-term continuity of care and healthcare utilization for CHD patients,” the authors wrote.

They also note that the next wave of research into patients lost to follow-up should focus on understanding the true barriers to care, designing additional measures that mitigate the numbers of families who are lost and identifying appropriate counseling during preliminary post-surgical cardiology visits to make sure families know the risks to health that are associated with future lack of follow up.

Children’s National ranked among top children’s hospitals nationwide

Children’s National in Washington, D.C., was once again ranked as a top hospital in the nation by the U.S. News & World Report 2026-27 Best Children’s Hospitals annual rankings. This marks the 10th straight year Children’s National has made the Honor Roll, a distinction awarded to only 10 children’s hospitals nationwide.

Children’s National also ranked in all 11 specialty services and is the highest U.S. News ranked children’s hospital in Washington, D.C, Maryland and Virginia. Recently, U.S. News introduced pediatric & adolescent behavioral health as a service line in its rankings. While there are no ordinal rankings for behavioral health, the Children’s National program was named one of the top 50 programs in the country for the third year in a row.

“We’re so proud to reach this milestone of being named among the nation’s top children’s hospitals for the 10th year in a row,” said Michelle Riley-Brown, MHA, FACHE, president and chief executive officer of Children’s National. “Our leadership in specialties like neurology, cancer, neonatology, and diabetes and endocrinology underscores our belief that kids are our everything. It also shows what’s possible when our teams bring their expertise, commitment and heart to make sure every child receives the best care.”

The annual rankings are the most comprehensive source of quality-related information on U.S. pediatric hospitals and recognize the nation’s top 50 pediatric hospitals based on a scoring system developed by U.S. News.

“Earning a place on U.S. News’ Best Children’s Hospitals list is a testament to Children’s National’s dedication to clinical excellence and patient safety,” said Ben Harder, chief of health analysis and managing editor at U.S. News. “These rankings highlight the standout hospitals in each specialty and each region.”

The bulk of the score for each specialty service is based on quality and outcomes data. The process includes a survey of relevant specialists across the country who are asked to list hospitals they believe provide the best care for patients with the most complex conditions.

The Children’s National specialties ranked in the top 10 nationally by U.S. News are:

The other specialties ranked among the top 50 are Behavioral Health, Cardiology and Heart Surgery, Nephrology, Pulmonology and Lung Surgery, and Urology.

Podcast: Health Professions Education Research: Training Better Doctors, Improving Care for Patients

Fetal echocardiography and neonatal pulse oximetry together can improve global congenital heart disease detection

Pulse oximiter on baby's foot

Technologies in both the prenatal and postnatal period, including fetal echocardiography and neonatal pulse oximetry screening, can and should be paired to try and achieve universal detection of CHD for infants around the world.

Prenatal detection of congenital heart disease (CHD) using ultrasound and the implementation of standardized pulse oximetry screening can both play an important role in decreasing infant mortality and morbidity worldwide, according to a review article in the International Journal of Neonatal Screening.

Lead author Anita Krishnan, MD, advanced imaging cardiologist, and a team from Children’s National including national and international leaders in implementation of both modalities, highlighted how both approaches can and should be applied wherever possible around the world. They also noted that adaptations and novel technology applications should be harnessed where necessary to address the challenges of resource limited settings.

“Given variable availability of fetal cardiology expertise within and between regions, screening for critical and severe CHD is best done in an approach that partners prenatal and postnatal testing with a specific plan for each country that reflects the patient population, availability and skills of providers, and access to technology,” the authors wrote. “Together, technologies in both the prenatal and postnatal period can be paired to achieve close to universal detection of CHD for infants in the perinatal period.”

Children’s National leads the way

Children’s National performs more than 4,000 fetal ultrasounds each year, making it one of the most experienced centers in the United States at finding these conditions and planning for their care. Birth planning protocols based on fetal diagnosis that were created two decades ago by the team at Children’s National and led by Mary Donofrio, MD, have become part of the extensive fetal cardiology care guidelines in use around the world.

Additionally, since 2009, Gerard Martin, MD, and team at Children’s National including Lisa Hom, RN, Esq, have been at the forefront of a national cohort of clinicians helping to implement screening for newborns in every birthing hospital. Findings from long-term implementation studies conducted by Children’s National and Holy Cross Health in Maryland have allowed for further refinement of the pulse oximetry algorithm and establish the scientific evidence for its benefits and effectiveness.

Read the full article: The Dual Role of Neonatal Pulse Oximetry Screening and Fetal Echocardiography in Congenital Heart Disease Detection Around the World

Additional Children’s National authors: Carolyn Sommer, MD, Chinenyenwa Mpamaugo, MD, Dr. Donofrio, Dr. Martin and Ms. Hom.

Specialized care access linked to survival rates of adults with congenital heart disease

doctor listening to girl's heart

People with congenital heart disease (CHD) had higher rates of death and disability if they lived in a state with lower household incomes and more uninsured residents.

People with congenital heart disease (CHD) had higher rates of death and disability if they lived in a state with lower household incomes and more uninsured residents, according to a data analysis led by researchers at Children’s National and published in the Journal of the American Heart Association (AHA).

“Understanding how social and economic factors can influence survival and outcomes is essential,” senior author Anitha John, MD, PhD, medical director of the Washington Adult Congenital Heart Program at Children’s National, said in an  AHA press release about the study. “Long-term outcomes and quality of life depend heavily on access to specialized, lifelong care for people with congenital heart disease.”

What it means

The researchers analyzed the Global Burden of Disease Study and U.S. Census data from 1990-2021 and found higher rates of death and disability for people with CHD if they lived in states that had lower incomes and fewer insured people. The data set included records for more than 300,000 people across the United States.

The authors hypothesize that these differences may be because people in states with higher income levels and rates of health insurance are more likely to have easier access to specialized care and treatment from adult CHD cardiologists.

As recommended by the evidence-based AHA/American College of Cardiology guidelines, adults with CHD require lifelong, regular access to specialized cardiac care to stay healthy.

Why it matters

“Seeing how these factors affect patients long term allows us to better identify people at highest risk for complications,” Dr. John added. “Then we can work toward improving access and reducing care gaps for people who have congenital heart disease.”

The authors note that the research re-emphasizes the importance of expanding access to expert care for CHD, particularly in under-resourced regions of the United States. Doing so could be a major factor in improving survival and quality of life for adult CHD patients.

 

Children’s National honored as 2026 AHA Foster G. McGaw Finalist

Children's National staff celebrating with pompomsThe American Hospital Association (AHA) announced today that Children’s National is one of three finalists for the 2026 Foster G. McGaw Prize, which recognizes hospitals and health systems for outstanding community service. Children’s National was honored for the following programs that advance child health, support families and strengthen communities across Washington, D.C.:

  • Child Health Advocacy Institute Advocacy Education program, a national model for socially accountable, interprofessional advocacy education for medical students, residents, and practitioners.
  • Early Childhood Innovation Network, a collaboration that advances innovative programs, research, and policy to ensure that generations of children and families in Washington, D.C., can build lifelong health and wellbeing.
  • Improving Pediatric Asthma Care in the District of Columbia, a program aimed at reducing the frequency of emergency asthma episodes.
  • Family Lifestyle Program (FLiP) that addresses food insecurity and diet-related chronic diseases through its Patient Navigator and Produce Prescription initiatives. For the past three years, FLiP Patient Navigators have connected more than 825 families to nutritious food, culturally appropriate nutrition education, and health-promoting community resources.
  • Conway Nursing Pathway Program that helps aspiring nurses, called Pathfinders, launch rewarding careers in pediatric nursing at Children’s National.

You can see the winner and full list of finalists here.

Children’s National Boeing School Wellness Symposium brings together 200+ health and education leaders

Keynote speaker, Carey M. Wright, EdD, Maryland state superintendent of schools, Maryland State Board of Education

Keynote speaker, Carey M. Wright, EdD, Maryland state superintendent of schools, Maryland State Board of Education

More than 200 attendees from 70 local and national organizations took part in a half-day, in-person School Wellness Symposium that fostered networking and spotlighted leading health and education partnerships that are advancing student wellness. The event, sponsored by The Boeing Company and held at the Children’s National Research & Innovation Campus, featured the School-Friendly Health Systems (SFHS) national movement founded at Children’s National, the statewide School-based Wellness Initiative at the Medical University of South Carolina’s Boeing Center for Children’s Wellness (MUSC BCCW) and other innovative collaborations. This event was informed by Children’s National community and school health leaders visiting the MUSC BCCW in Charleston, SC earlier this year.

Symposium highlights

Danielle Dooley, MD, MPhil, FAAP, pediatrician and medical director for Community and Population Health at Children’s National, who led the organization of the event with a school partnerships team, provided opening remarks on the importance of health and education systems partnering with families to improve health and wellness in the learning environment.

“In serving students, staff and families, partnerships are critical to fill the gap, and there is no school, agency, hospital, community health center or other organization that can do it alone, so these partnerships are critical,” Dr. Dooley said. This lesson has been critical to the success of the Collaborative for Attendance Resources in Education and Health (CARE-H) that was included in a spotlight presentation. This nearly 10-year partnership combines the efforts of the District of Columbia Public Schools (DCPS), Children’s National, and parents and caregivers to support school attendance and address health and social needs that impact it.

Cara Biddle, MD, MPH, senior vice president of Community Pediatric Health; chief of General Pediatrics and Community Health and Torine Creppy, vice president of Community Engagement & Impact at Children’s National; president of Safe Kids Worldwide, emphasized the importance of working beyond the hospital walls in the community where kids live, go to school and play.

Jessica Williford, senior director of State Advocacy and Global Engagement at Boeing South Carolina, gave a warm welcome to the event celebrating and advancing school wellness and School-Friendly Health Systems through the largest gathering of children’s hospitals. “As we sat in the auditorium of Children’s Research and Innovation Campus (a direct investment of the Boeing Company), we were reminded of the great opportunity to learn, collaborate and create innovative programs for children and families.”

Boeing Company leaders Lindsay Leonard, Vice President of Global Engagement, and Jessica Williford, Senior Director of State Advocacy and Global Engagement for South Carolina.

Boeing Company leaders Lindsay Leonard, Vice President of Global Engagement, and Jessica Williford, Senior Director of State Advocacy and Global Engagement for South Carolina, addressed the audience.

The keynote speaker, Maryland State Superintendent of Schools Carey M. Wright, Ed.D., shared insights on the reasons children are chronically absent from school, including mental health challenges and fears due to safety and immigration concerns. As pediatricians have one of the most trusted relationships with families, she cited the critical role they can play in supporting their patients through asking about school and attendance.

“When kids aren’t in school, they aren’t learning. Child health and well-being require a community effort, and it’s vital that school programs are designed with educators at the table,” said Dr. Wright.

Spotlight presentations and panels of experts shared examples of transformational health and education collaborations that involved data-sharing, wellness initiatives, school-based health services and policy and systems change efforts across the country to improve children’s health and educational outcomes. Sarah Piwinski, DHA(c), MPA, director of the Institute for Community Health at MUSC, stated that “health and education are inseparable, and if we think about them separately, we are doing a disservice to our programs and the families we can reach.” Throughout the day, many speakers expressed that fragmented systems create gaps in care, emphasizing the importance of hearing educator’s perspectives and inviting leaders into shared space to create goals and accountability for this work.

The previous day, 40 members from 23 children’s hospitals attending a SFHS National Collaborative meeting visited two innovative DC public charter schools: DC Bilingual School, a dual language immersion school in Spanish and English, and Briya Public Charter School, a two-generation public charter school. This set the tone for a powerful closing to the symposium with remarks from Nicole Travers, MS, senior director of Strategic Partnerships at the DC Charter School Alliance who explained that academic success for students requires more than strong instruction. “It requires a network of community partnerships and wraparound services that ensure students are ready to learn each day,” she said.

This event was sponsored by The Boeing Company and Children’s National.

Executive function interventions may be critical to long-term mental health in autism

People with autism who struggle with challenges related to executive function are more likely to suffer poor mental health outcomes, according to findings from a large-scale longitudinal study published in The Journal of Child and Adolescent Psychiatry.

Lead author of the study, Lauren Kenworthy, PhD, division chief of Neuropsychology at Children’s National, recently appeared on Mind the Kids, a podcast hosted by the Association for Child and Adolescent Mental Health (ACAMH), to discuss the findings. Dr. Kenworthy touched on why interventions targeted to address executive function challenges, like Unstuck and On Target, may be critical tools to ensure better mental health outcomes for autistic youth and young adults.

What it means

Executive functions are higher order cognitive abilities that allow people to regulate their thoughts, feelings and behaviors to meet the demands of their environment. People with executive function challenges often struggle with several areas of self-regulation that can truly impact daily life, such as inhibition, flexibility and working memory.

“We’ve known for a long time now that executive functions are strongly linked to mental health, including depression, anxiety and aggression, for all of us,” Dr. Kenworthy told podcast host Clara Faria, PhD. “We’ve also known for a long time that executive functions and mental health are really challenging areas for a lot of people with autism.”

Despite the significance of executive function in autism,  studies examining the trajectory and impact of these challenges long term have been difficult to complete in a comprehensive way. Small sample sizes and/or limited age ranges have prevented researchers from capturing a true notion of how executive function and mental health outcomes develop over time.

Why it matters

This study is the first large-scale longitudinal study of executive function and mental health in autism. It shows the lasting effect of executive function challenges on autistic people, especially drilling into specific subcategories of symptoms such as aggression, anxiety and depressive mood and finding that many of these symptoms only worsen over time.

Children’s National leads the way

Dr. Kenworthy and her study co-authors concluded from the findings that interventions targeting executive function skills, especially flexibility, in autistic children are critical to a child’s well-being throughout their lives. The right interventions may reduce the burden of both the executive function challenges themselves and their impact on a child’s mental health over time.

Unstuck and On Target, a set of tools created by Dr. Kenworthy and a team of researchers from Children’s National and Children’s Hospital Colorado, is one example of an evidence-based intervention that is ready to be deployed in schools and clinics.

“We developed executive function interventions designed to improve kids’ ability to be flexible, make plans and set goals,” Dr. Kenworthy notes in the podcast. “And we’ve designed them to be delivered in the public school system with fidelity by classroom teachers and special educators because every kid gets to go school. Some of their most important work occurs in school so it’s also the real-world setting where they need the help.”

Listen to the ACAMH podcast, Beyond the Diagnosis: Supporting Executive Function to Improve Autism Mental Health, and read the full study, Executive function challenges persist into young adulthood and predict mental health outcomes in autism.

Children’s National and Virginia Tech deepen pediatric AI collaboration to accelerate innovation for children

Experts from academia, clinical care, industry and government recently gathered  to explore how artificial intelligence (AI) is rapidly reshaping pediatric health, from early-stage scientific discovery to real-world clinical care.

Hosted by Children’s National Hospital and Virginia Tech, the third annual AI for Pediatric Health Symposium highlighted the growing momentum behind the Pediatric Health AI Innovation Hub, a collaborative initiative designed to bring together clinicians, researchers, engineers and data scientists to accelerate AI-driven innovation focused specifically on children.

Held at Virginia Tech’s Academic Building One in Alexandria, Virginia, the symposium showcased how Children’s National and Virginia Tech are helping lead the national conversation around the future of pediatric AI and the importance of developing technologies designed specifically for children, not simply adapted from adult medicine.

“Children’s health presents some of the most important and complex opportunities for artificial intelligence,” said Catherine Bollard, MBChB, MD, chief research officer at Children’s National. “But meaningful progress only happens when AI development is grounded in real clinical environments and driven by the needs of patients, families and care teams. That is what makes this collaboration so important.”

Over the last three years, the partnership between Children’s National and Virginia Tech has evolved into a broad effort to build infrastructure, research pipelines and translational pathways capable of moving pediatric AI innovation from concept to clinical impact.

Building on that momentum, symposium organizers announced the launch and continued support of the Children’s National & Virginia Tech Pediatric Health AI Innovation Hub.

“Children have historically been underrepresented in AI research despite having fundamentally different physiology, disease patterns and developmental needs,” said Marius George Linguraru, DPhil, MA, principal investigator in the Sheikh Zayed Institute for Pediatric Surgical Innovation and director of the division of AI Research at Children’s National. “We have an opportunity to build pediatric AI the right way from the beginning by developing and validating these technologies specifically for children and within pediatric clinical settings.”

Organizers said that advancing pediatric AI will require close collaboration between pediatric clinicians, biomedical researchers and AI experts across institutions.

“Pediatric health presents some of the most complex challenges for artificial intelligence, from limited data to rapidly changing biology,” said Naren Ramakrishnan, PhD, University Distinguished Professor at Virginia Tech and director of the university’s Sanghani Center for Artificial Intelligence and Data Analytics. “Over the past two iterations of this symposium, we’ve seen successful partnerships emerge between Children’s Hospital and Virginia Tech, and we hope to build on that momentum by creating even more collaborations and relationships moving forward.”

For Children’s National leaders, the symposium represented more than an annual gathering. It reflected Children’s National Hospital’s position as a leading hub for pediatric AI innovation and translational research. “Artificial intelligence will play a major role in the future of pediatric medicine,” Bollard said. “Our responsibility is to ensure these technologies are developed thoughtfully, ethically and in ways that ultimately improve the lives of children and families.”

Speakers highlighted how advances in data infrastructure, machine learning and clinical integration are beginning to translate into practical applications.

“AI has a role in the delivery of pediatric healthcare and across the entire ecosystem, from basic discovery science to translation to clinical implementation,” said Michael Friedlander, PhD, executive director of the Fralin Biomedical Research Institute at VTC and Virginia Tech vice president for health sciences and technology. “We need to embrace AI at all levels, from our basic scientists to our translational researchers to our clinical healthcare providers. Our institutions will continue to make major commitments to move this work forward.”

“We are on the precipice of an extraordinarily exciting time in pediatric healthcare, discovery, translation and implementation,” Friedlander said.

The keynote address at the symposium was from Rod Tarrago, MD, chief medical information officer for pediatrics at Amazon Web Services, who explored how AI and advanced technologies could support the “quadruple aim” in healthcare by improving patient outcomes and patient experiences, reducing costs and supporting clinician well-being.

Erika Kim, PhD,Resilient Systems Program Manager for Advanced Research Projects Agency – Health introduced the agency’s Pediatric Care eXpansion program and how to scale data and knowledge networks across the United States. Other invited speakers included Kirk Roberts, PhD, from the University of Texas Health Center and Ananth Annapragada, PhD, of the Baylor College of Medicine, Texas, who spoke about natural language processing in clinical notes and AI automation, respectively.

Sally Allain, MBA, MS, Virginia Tech’s chief health sciences growth and innovation officer, moderated the second session, which focused on AI technologies and systems powering biomedical discovery and clinical applications. Sarah Clinton, PhD, Virginia Tech’s health sciences associate vice president for planning and strategy, moderated the third session, highlighting how AI is helping researchers uncover new insights into disease biology and risk. Speakers emphasized that while enthusiasm around AI continues to grow, successful implementation in pediatric healthcare depends on ensuring tools are reliable, safe and thoughtfully integrated into clinical workflows. Researchers from Children’s National discussed approaches to evaluating AI tools designed for pediatric mental health settings, while collaborators from Virginia Tech examined how machine learning systems respond as patient conditions worsen.

The symposium reflected the expanding national ecosystem surrounding pediatric AI research, with participation from industry leaders, federal agencies and academic institutions. Children’s National Hospital and Virginia Tech are leading the way in exploring how Al is advancing pediatric health – from research and data to bedside care – while fostering collaboration and innovation to improve outcomes for children.

Faster diagnosis and treatment of Kawasaki disease are key to preventing heart-related complications

Headshot of Ashraf Harahsheh

“Kawasaki disease is highly treatable, yet too many children around the world face delayed diagnosis or limited access to care,” says Dr. Ashraf Harahsheh, an international Kawasaki disease expert.

Delayed diagnosis and barriers to treatment can increase the risk that a child with Kawasaki disease may develop a serious cardiac condition, according to a science advisory published in the Journal of the American Heart Association.

The advisory calls for global collaboration in diagnosis, care and research to reduce persistent care gaps and ensure children have timely access to diagnosis and treatment for Kawasaki disease no matter where they live in the world.

The advisory’s writing group was chaired by Ashraf S. Harahsheh, MD, director of the Kawasaki Disease Program and the Quality Outcomes in Cardiology Program, at Children’s National Hospital. In an AHA press release, Dr. Harahsheh said, “This science advisory underscores the power of international collaboration to advance research and improve care for patients everywhere. By sharing data, expertise and best practices, we can reduce disparities and improve heart health outcomes for children with Kawasaki disease, wherever they live.”

Why it matters

The media alert points out that more than 4,200 children are diagnosed with Kawasaki disease in the U.S. each year. Kawasaki disease is a rare but serious illness that can cause inflamed blood vessels throughout the body. If untreated, children with Kawasaki disease develop coronary artery aneurysms around 25% of the time. However, prompt diagnosis and treatment with intravenous immunoglobulin (IVIG) can lower the risk of coronary artery aneurysm to less than 5%.

Unfortunately, the authors note that Kawasaki disease management has improved mostly in large, experienced and economically advanced countries, while less advanced areas continue to face challenges in identifying Kawasaki and treating it early enough with IVIG to prevent potentially deadly coronary artery aneurysms.

What’s next

The AHA news release includes several key takeaways including:

  • Strengthening diagnostic and treatment capacity in regions where access to care is most limited is essential.
  • Most current Kawasaki disease collaborative networks lack formal funding, but strong research collaborations, shared expertise and coordinated treatment plans have been responsible for diagnosis and treatment advances.
  • International collaborations in Kawasaki disease must consider the cultural needs of local communities, prioritize uncovering and reducing barriers to care, monitor results to improve outcomes, and promote evidence-based care across regions, especially in lower- and middle-income countries.
  • Patients, families and advocacy groups must be included in any collaborative effort in Kawasaki disease to support patient-centered care and improve access to care.

The science advisory was prepared by a volunteer writing group on behalf of the American Heart Association’s Rheumatic Fever, Endocarditis, Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young (the Young Hearts Council).

“Kawasaki disease is highly treatable, yet too many children around the world face delayed diagnosis or limited access to care,” Dr. Harahsheh says.

Read the news release from the American Heart Association and the full science advisory, Importance of Fostering International Collaboration for Optimal Outcomes of Kawasaki Disease Worldwide: A Science Advisory From the American Heart Association

Podcast: Care Champions: The science, leadership and compassion behind pediatric nursing

At-home buprenorphine initiation could improve access for adolescents

Headshot of Sivabalaji Kaliamurthy, MD

A recent study led by Sivabalaji Kaliamurthy, MD, director of the Addictions Program at Children’s National Hospital, revealed that adolescents diagnosed with opioid use disorder (OUD) can successfully start buprenorphine treatment at home within one week.

A recent study led by Sivabalaji Kaliamurthy, MD, director of the Addictions Program at Children’s National Hospital, revealed that adolescents diagnosed with opioid use disorder (OUD) can successfully start buprenorphine treatment at home within one week.

Published in the Journal of Child and Adolescent Psychopharmacology, the study also found that some patients who did not initiate at-home treatment within the first week were able to do so at later follow-up attempts.

“Adolescents face significant barriers to accessing medications for OUD,” said Dr. Kaliamurthy, lead author of the study. “Our results suggest that supported at-home buprenorphine initiation may offer a safe, feasible and accessible pathway to treatment.”

The big picture

The study evaluated 19 patients aged 18 years and younger between 2022 and 2024 who had a diagnosis of moderate or severe OUD. A clinic physician provided education on at-home buprenorphine initiation, including instructions for use and discussion of associated risks. Adolescents were instructed to begin buprenorphine when they reached their maximum tolerance for withdrawal symptoms or when their subjective opioid withdrawal scale (SOWS) score exceeded 17.

On day 1, participants initiated treatment with 2/0.5 mg buprenorphine/naloxone, with one repeat dose after 30 minutes, followed by additional 2/0.5 mg doses every 2 hours as needed, up to a maximum dose of 8/2 mg. On day 2, participants began with the total dose taken on day 1, followed by 2/0.5 mg every 2 hours as needed based on subjective cravings, up to a maximum daily dose of 16 mg. On day 3, participants were instructed to continue taking the total dose reached on day 2 through their 1-week follow-up appointment with the physician. Supportive medications were also given to take as needed.

By the 1-week follow-up, 10 of the 19 adolescents had successfully initiated treatment at home. An additional 3 adolescents were later successful in initiating treatment at home at a later date. Six participants did not continue.

The hold up in the field

This is the first study to evaluate at-home buprenorphine initiation in adolescents 18 years and under. Researchers also identified several barriers to successful treatment initiation, including insurance coverage, transportation and housing instability and relapse. At the same time, the authors noted that multiple aspects of the protocol likely contributed to successful at-home initiation, including bilingual materials, SOWS-guided timing and anticipatory guidance to reduce discomfort or misuse, such as avoiding smoking or vaping before dosing.

Children’s National leads the way

The Addictions Program at Children’s National is one of the only pediatric substance use disorder programs in the region and continues to advance treatment options for children and adolescents with addiction. Dr. Kaliamurthy and colleagues have led multiple studies focused on youth and opioid use disorder, helping build evidence for innovative approaches to care. Read more about their related research:

What’s next

While larger studies are needed to confirm efficacy and define best practices, the authors say the findings offer early support for more accessible treatment models, including home initiation.

“This work highlights an important shift toward models that expand access and meet youth where they are, especially when higher levels of care are not available,” said Dr. Kaliamurthy.

Additional authors from Children’s National include – Emma Straton, BA.

Read the study, Home Initiation of Buprenorphine in Adolescents with Opioid Use Disorder: A Preliminary Feasibility Study, in the Journal of Child and Adolescent Psychopharmacology.

Advancing pediatric hospital medicine through research and collaboration

two doctors conversing

The program is designed around a cohort model that emphasizes shared learning, mentorship and collaboration.

In pediatric hospital medicine, the moments that happen inside a hospital often represent the most critical point in a child’s care. Physicians and researchers working in this field not only treat acute illness but also ask deeper questions about how hospital care can improve outcomes for children and families across diverse communities.

At Children’s National Hospital, The Health Excellence Academic Research in Pediatric Hospital Medicine (HEAR-PHM) program brings together clinicians and researchers from across the country to strengthen scholarship in pediatric hospital medicine and support the next generation of investigators working in the field.

Launched in September 2024, the inaugural HEAR-PHM cohort includes 14 scholars from 11 academic institutions nationwide. Participants range from fellows early in their training to assistant professors developing independent research programs. Together, they form a collaborative learning community focused on advancing research that improves care for hospitalized children. Cohort 2 is currently underway, and Cohort 3 is scheduled to launch in Fall 2026.

Building a community of scholars

The program is designed around a cohort model that emphasizes shared learning, mentorship and collaboration. Participants engage in structured small-group sessions with national experts, work together on research projects and build professional networks that extend beyond their home institutions.

Three core components anchor the program:

  • Small-group learning sessions led by faculty with expertise in pediatric research and population health
  • A capstone research project that allows scholars to apply new skills while developing original scholarship
  • Peer networking and mentorship, helping participants build relationships with colleagues across the field

The goal is not only to support individual projects but also to cultivate a community of physician-scientists who can collaborate long after the program concludes.

Identifying the research questions that matter most

As part of the program’s launch, organizers conducted a national scholarship needs assessment among participants. The survey explored areas where pediatric hospital medicine researchers are most interested in focusing their work.

The assessment drew responses from fellows, clinical instructors and assistant professors across participating institutions. Scholars expressed strong interest in studying how social and clinical environments influence the care children receive in hospitals and how systems within healthcare can better support patients and families during vulnerable moments. These insights help shape the program’s curriculum and ensure the training aligns with the questions clinicians are seeing firsthand in their daily work.

A growing field with opportunity for innovation

Pediatric hospital medicine is a relatively young subspecialty that continues to evolve rapidly. Programs like HEAR-PHM reflect a broader effort to strengthen research infrastructure within the field and encourage collaboration across institutions. By bringing together investigators at different career stages, the program helps accelerate the exchange of ideas and supports research that can translate into better care practices in pediatric hospitals.

For Children’s National, initiatives like HEAR-PHM also reflect the institution’s broader commitment to advancing pediatric research and creating opportunities for clinician-scientists to develop new approaches to care. As the inaugural cohort continues its work, the program is helping lay the foundation for a national network of pediatric hospital medicine researchers focused on improving outcomes for children when they need hospital care the most.

Read the full study in the American Academy of Pediatric’s Hospital Pediatrics journal here. Authors from Children’s National include Amina Touma; Kavita Parikh, MD, MSHS and Gabrina Dixon, MD, Med.

Shaping the future of pediatric medical education and residency training

Cover of the Graduate Medical Education in Pediatrics: From Basic Processes to True Innovation.Multiple experts from Children’s National Hospital contributed to the inaugural edition of Graduate Medical Education in Pediatrics: From Basic Processes to True Innovation.

“Contributing to this chapter was an opportunity to reflect on how pediatric education must continue evolving to meet the needs of both learners and the patients and families they serve,” said Dr. Barber. “By embracing innovation, collaboration and adaptability, we can better prepare the next generation of pediatricians for a rapidly changing healthcare landscape.”

“Developing new training pathways is essential to ensuring our workforce is equipped to address emerging challenges in child health,” said Dr. Falusi. “Through this work, we aimed to provide a practical framework that empowers institutions to design programs that are responsive and impactful.”

These chapters address essential challenges and innovations in pediatric education, highlighting Children’s National Hospital’s dedication to advancing medical training and enhancing patient care.

Bold research and novel collaborations reimagine a brighter future during REI Week 2026

  • REI Week 2026

  • Nathan Kuppermann introduces Holden Thorp during REI Week.

  • Nathan Kuppermann, Richard Childs and Catherine Bollard during REI Week.

  • CNRI leadership with Adam Carroll.

  • Pamela Hinds presents Lauren Clark during REI Week programming.

  • Kelly Gebo presents during REI Week.

  • Presenters of the joint AI lecture during REI Week with Nathan Kuppermann.

  • Jill Joseph delivers a lecture during REI Week.

  • Howard Bauchner presents during REI Week.

  • Holden Thorp delivers remarks during REI Week.

  • Panel discussion focused on drug and device development during REI Week.

  • Matthew Bramble presents during REI Week.

  • Catherine Bollard speaks during REI Week programming.

  • Nathan Kuppermann and colleagues view posters during a REI Week poster session.

  • REI Week staff on Tuesday of the event.

  • Attendees gather for the REI Week awards ceremony.

  • The auditorium during the REI Week awards ceremony.

  • Poster session held on Tuesday during REI Week.

  • Members of the Academic Research Operations team during REI Week.

  • Members of the Academic Research Operations team at Children’s National.

  • Aaron Carroll presents during REI Week 2026.

  • Poster session held on Wednesday during REI Week.

  • Panel discussion focused on media and communication during REI Week.

  • Nathan Kuppermann participates in a Safe Kids event during REI Week.

  • Poster session held on Thursday during REI Week.

  • Research Sponsored Projects and Business Services staff with Nathan Kuppermann during REI Week.

  • REI Week staff members during the event.

  • Peter Hotez presents during REI Week.

  • Nam Tran presents during REI Week.

  • Nathan Kuppermann speaks during REI Week.

For five days in April, the hallways, auditoriums and virtual platforms of Children’s National Hospital became a space for the kind of honest and necessary conversations that move pediatric science forward. Research, Education & Innovation (REI) Week 2026, held April 13–17, brought together investigators, clinicians, trainees and partners across disciplines to grapple with the theme: reimagining a brighter future for children through bold research and novel collaborations. REI Week remains a cornerstone of the institution’s academic mission 16 years in and this year’s edition made clear that progress in pediatric health demands not just discovery, but clarity of purpose and the courage to push forward.

Making the case for pediatric-first development

Innovation Day opened the week at the Research & Innovation Campus with a panel discussion on drug and device development. Panelists were clear that making pediatric drug and device development a genuine priority is essential to delivering safe, effective care.

A media and social media panel pushed researchers toward another uncomfortable question: why should anyone outside this building care about what we do? Speakers explored how to frame research so it resonates beyond academic circles, making the case that storytelling and audience awareness are not soft skills but a part of the job.

A Shark Tank-style session showcased diverse artificial intelligence (AI) project proposals aimed at advancing pediatric care and research, with teams presenting bold ideas in a competitive format.

Standing up for science and innovation

Holden Thorp, PhD, editor-in-chief of Science, set a defining tone for the week in his Monday keynote, speaking frankly about the importance of resisting external pressures and standing up for scientific integrity. His message — that science must hold its ground even when it’s difficult — echoed throughout the days that followed.

Richard Childs, MD, assistant U.S. surgeon general and scientific director of the National Heart, Lung and Blood Institute, reinforced why sustained investment matters, highlighting how resources and infrastructure at the National Institutes of Health (NIH) enable the kinds of accomplishments that transform care. Kelly Gebo, MD, MPH, dean of the Milken Institute School of Public Health at George Washington University, grounded leadership in something simpler: “Listen before acting. Stay grounded in values. Adapt to change. Explore new funding. Communicate clearly. Lead with empathy.”

A trust problem, not a knowledge problem

Midweek programming zeroed in on research communication and didn’t flinch. Howard Bauchner, MD, vice chairman of pediatrics at the Boston University School of Medicine, delivered the Larrie Greenberg Grand Rounds Lecture with a call for a cultural shift: quality, not quantity, of publications must become the norm for the research enterprise to regain credibility.

The Jill Joseph Grand Rounds Lecture with Aaron Carroll, MD, MS, president and CEO of AcademyHealth, reframed how the field thinks about science dissemination. The problem, Dr. Carroll argued, is not that the public lacks knowledge, it is that they lack trust. He urged a shift toward solutions-based research and challenged researchers to understand the difference between relative and absolute risk, noting that headlines almost always reach relative figures. If science wants to grab attention responsibly, it has to understand how attention actually works.

Peter Hotez, MD, PhD, professor of pediatrics and molecular virology and microbiology at Baylor College of Medicine, co-director of the Texas Children’s Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine, brought the stakes into sharp relief in his lecture on vaccines and immunizations in an era of anti-science, describing his personal and professional journey, including writing “Vaccines Did Not Cause Rachel’s Autism”, as part of an ongoing effort to counter misinformation and advocate for the families most affected by it.

Lauren Clark, PhD, RN, FAAN, professor and Shapiro Family Endowed Chair in Developmental Disability Studies at UCLA’s Joe C. Wen School of Nursing, closed the communication thread with a pointed observation: if researchers never leave their own scientific community, they are missing the boat. She emphasized that plain language is a strategy, not a compromise.

From global health to the clinic floor

Matthew Bramble, PhD, assistant professor and data sciences faculty member at Children’s National, delivered the Global Health Sponsored Lecture on ending the scourge of Konzo in the Democratic Republic of Congo. His work in this isolated environment — where populations depend heavily on cassava — could unlock information relevant far beyond Konzo itself, potentially shedding light on diseases like ALS.

The joint Lecture on AI featured two complementary perspectives on machine learning’s growing role in care delivery. Hooman Rashidi, MD, MS, associate dean of AI in medicine, professor and endowed chair of Lombardi-Shinozuka Experimental Pathology Research at the University of Pittsburgh School of Medicine proposed a mixed approach with a human in the loop as the responsible path forward. Nam Tran, PhD, MS, professor of pathology, associate dean of biobanking and medical director of Point of Care Testing at the University of Pittsburgh, highlighted AI’s potential in austere settings, field medicine, military contexts and disaster response, where speed and limited resources put a premium on intelligent decision support.

What the abstracts reveal

This year’s poster sessions drew more than 450 abstracts spanning 46 research categories — a record number that reflects both the depth of work underway at Children’s National and the range of challenges the institution has committed to tackling. Oncology, neuroscience and neuroprotection, cancer immunology and bone marrow transplantation represented some of the largest clusters of work, with investigators exploring everything from gene therapy for beta-thalassemia to advanced neuroimaging frameworks for fetal and neonatal populations. Digital innovation, data science and AI also drew a strong showing, with studies applying machine learning to EEG-based cognitive assessment, predictive modeling and clinical decision support, reflecting the institution’s growing investment in responsible, data-driven care.

Equally notable was how questions of access and reach have woven themselves into categories that might not have carried that framing in prior years. Research on firearm violence, pathways to mental health care and the downstream effects of social conditions on pediatric outcomes appeared across multiple categories. Community research submissions highlighted school-based telehealth programs and outreach initiatives that extend Children’s National’s reach into underserved communities across the Washington region. Psychology and wellness, quality improvement and treatment compliance rounds out a body of work that asks not just what works scientifically, but who benefits and whether they can actually access what works.

Global and climate health emerged as a distinct and growing area, with submissions connecting environmental conditions to pediatric disease burden and mortality. Taken together, this year’s abstracts capture a field that is translating molecular discoveries into clinical applications, integrating technology with intention and making sure research translates to care for children who need it most.

This year’s honorees

REI Week concluded Thursday with an awards ceremony honoring outstanding contributions across research, education and innovation.

Award winners:

POSTER SESSION AWARDS

Basic & Translational Research

Faculty: Yingshi Ouyang, PhD
“Opioid Receptor Expression in the Human Placenta and Placental Transcriptomic Alterations in Opioid Use Disorders”

Postdocs/Fellows/Residents: Margaret Hines, PhD
“Understanding the Role of Cranial Mesenchyme in Neural Tube Closure”

Postdocs/Fellows/Residents: Khatereh Khorsandi, PhD
“Reprogramming the Immunosuppressive Microenvironment to Enhance CAR T‑Cell Therapy in Diffuse Intrinsic Pontine Glioma”

Staff: Zara Hasnani
“Evaluation of Virus‑Specific T Cell Immunity in Pediatric Inflammatory Bowel Disease Patients on Biologic Therapy”

Graduate Students: Elton VanNoy
“Modulating DNA Methylation During CAR T Manufacturing to Enhance Immunotherapy for Pediatric Glioma”

Graduate Students: Woudasie Admasu
“Identification of Druggable Host Factors to Prevent RSV Infection Using CRISPR‑Cas9”

High School/Undergraduate Students: Akhil Chada
“Designing of PepMLM‑Based Peptide Binders to Target Tumor‑Specific Splice Event‑Derived Proteoforms in Pediatric High‑Grade Gliomas”


Clinical Research

Faculty: Matthew Bramble, PhD
“Pathways Involving Oxidative Damage Mitigation is Likely the Biological Risk Factor for the Development of Konzo”

Postdocs/Fellows/Residents: Maria Triantafyllou, MD
“Plasma Metabolomic Signatures for Diagnosis and Risk Stratification of Pediatric Sepsis in the Emergency Department”

Staff: Pooneh Roshanitabrizi, PhD
“Synthetic Dual‑Channel Color Doppler Echocardiography for Rheumatic Heart Disease Detection in Low‑Resource Settings”

Graduate Students: Jasmine Nguyen
“The Relationship Between Cloacal Complexity and Early Vaginal Stenosis After Cloaca Repair”

Graduate Students: Maria Straker Brito, MD
“High Airway Type‑III IFN Levels by Airway Epithelial Cells are Associated with Increased Pro‑Inflammatory Cytokines Production in the Airways”

Graduate Students: Artur Aharonyan, MS
“Automating AMPs: An AI Pipeline for Generating 3D‑Printable BioAMP Plates in Unilateral Cleft Lip and Palate”

Graduate Students: Jaisimar Singh
“Mechanical versus Non‑Mechanical Bowel Management in Children with Spina Bifida: A Cross‑Sectional Comparison of Patient‑Reported Symptoms”

High School/Undergraduate Students: Medha Pappula
“Integrating Multimodal Clinical Data with Large Language Models to Predict Outcomes in Pediatric Metabolic and Bariatric Surgery”

High School/Undergraduate Students: Keertana Senthilkumar
“Diagnostic Utility of Vascular Catheter Tip Cultures”


Community‑Based Research

Faculty: Katie Donnelly, MD, MPH
“Evaluating the Propagation of Firearm Violence After an Incident Event”

Postdocs/Fellows/Residents: Brittany Fitzpatrick, MD, MPH
“Walking Towards Equity: Enhancing Pediatric Pedestrian Safety Through Data‑Driven Solutions”

Postdocs/Fellows/Residents: Krithika Iyer, PhD
“Predicting Early Cognitive Risk Using Ultra‑Low‑Field MRI Brain Volumetry and Demographic Measures in Low‑Resource Settings”

Staff: Megan Lau
“A Longitudinal Examination of Social Support as a Mechanism of Change in Executive Function in a School‑Delivered Intervention for Adolescents with ADHD”

Graduate Students: Preeyanka Rao, MPH
“Comparison of Asthma Utilizations Across Different Medicaid Insurance Plans in the District of Columbia”

High School/Undergraduate Students: Riya Mehta
“Availability and Knowledge of Naloxone Distribution in an Urban Area”


Education, Training and Program Development

Faculty: Amy Wolfe, MD, MEd
“A Missed Conversation: Spirituality as a Persistent Gap in PCCM Communication Training”

Postdocs/Fellows/Residents: Taylor Goodman, MD
“The POCUS Pathway: A Novel Point‑of‑Care Ultrasound Longitudinal Curriculum for Pediatric Residents”

Postdocs/Fellows/Residents: Jennifer Bertollo, PhD
“Online Educator Training for an Executive Function Intervention: Mixed Methods Educator Feedback and Impact on Adoption”

Staff: Tininka Rahman, MHA
“Establishing a Community Engaged Research and Training (CERT) Hub at Children’s National”

Graduate Students: Novelle Leach
“PCIT and SPACE Parenting Interventions: Are They Meeting the Needs of Young Children with Neurodevelopmental Disabilities and Their Families?”


Quality and Performance Improvement

Faculty: Jessica Lazerov, MD, MBA
“Using LEAN Methodology to Improve Immunization Reconciliation and Vaccination Rates”

Postdocs/Fellows/Residents: Maya Gibson, MD
“Evaluating Blood Product Utilization on ECMO Following Implementation of Restrictive Transfusion Strategies”

Staff: Abhijeet Parida, MS
“HOPE4KIDS: AI‑Based Webtool for Neuro‑Oncology Segmentation and Volumetrics”

Graduate Students: Benjamin Upbin
“Caring for the Caregivers: Evidence Reveals a Support Gap for Caregivers of Autistic Youth”

High School/Undergraduate Students: Safinabonu Juraeva, MPS
“Diagnosing Primary Bottlenecks in the PICU‑to‑Floor Transfer Process to Improve Transfer Efficiency”


AI SHARK TANK EVENT WINNERS
Smart AI for Environments (SAFE) Kids App
Team:
Christopher Gable, DO
Sadiqa Kendi, MD, MPH
Fatemeh Naghiloo, MArch, MPH
Pooneh Roshanitabrizi, PhD
Nishad Prakash Kulkarni, MEng
Syed Muhammad Anwar, PhD
Youness Arjoune, PhD

StrepApp: AI‑Based Strep Throat Diagnosis from Smartphone Images
Team:
Raj Shekhar, PhD
Jeffrey Dome, MD, PhD
Rana Hamdy, MD, MSCE, MPH
Youness Arjoune, PhD
Trong N. Nguyen, PhD


INAUGURAL PLANET‑POSITIVE PIONEER AWARD

Demilade Haastrup, PharmD, RPh
“Decreasing Single‑Use Plastic Within the Pneumatic Tube System During Medication Transport Through a QI Initiative”


MENTORSHIP AWARDS (16th Annual)

Translational Research
Michael Keller, MD
Panagiotis Kratimenos, MD, PhD

Clinical Research
Eleanor R. Mackey, PhD


CHU FAMILY FOUNDATION AWARD

Katherine Ottolini, MD
“BOOST‑Milk Study: Bringing Oura Optimization Support to Milk”

Kristen Johnson, MD
“Exploring the Impact of AI‑Generated Plain Language Clinical Summaries on Caregiver Understanding”


THE SUZANNE FEETHAM NURSING RESEARCH SUPPORT AWARD

Olivia Miller, MA, BCBA, LABA
“Using Video Prompting to Teach Tracheostomy Tie Changes to Caregivers”

Shripriya Mohan‑Oneill, MSN, CPNP
“Artificial Intelligence Integration into Advanced Practice Nursing”


EXPLORATIONS IN GLOBAL HEALTH PILOT AWARDS

Sarah Mulkey, MD, PhD
“Understanding Environmental and Community Factors in Children with Prenatal Zika Virus Exposure in Colombia”

Meleah Boyle, PhD, MPH and Ann Mead, MPH
“Protecting Children’s Health in Local and Global Communities Through Environmental Sustainability Education”


ELDA ARCE TEACHING SCHOLAR AWARD

John Berger III, MD
Cardiac Critical Care Medicine

Sivabalaji Kaliamurthy, MD
Child and Adolescent Psychiatry


RESEARCH RANGERS

Winner: Sebastian
Fourth‑grade patient participant in REI Research Rangers

Looking ahead at a brighter future

The conversations held during REI Week 2026 continue throughout the year. They carry forward into labs, clinics and classrooms, and ultimately into the lives of the children and families this institution exists to serve.

That dialogue also extended online through The Lead in Peds Unplugged episodes featuring notable speakers from the week and leaders at Children’s National talking about the ideas, challenges and collaborations shaping pediatric health. These conversations included Dr. Holden Thorp, Dr. Kelly Gebo, Dr. Hooman Rashidi and Dr. Nam Tran, Dr. Patrick Hanley and Dr. Matthew Bramble.

REI Week also highlighted the teams and programs that support research across its full lifecycle, with the Clinical Research Unit, Innovation and Technology Transfer Office and Research Sponsored Projects and Business Services maintaining a visible presence throughout the week to engage investigators and answer questions. Opportunities for connection extended beyond formal sessions through events such as the “global health mix & mingle”, sponsored by the Global Health Initiative, which brought participants together to engage around Children’s National’s work in local and global communities. Educational programming continued through Children’s Academy of Pediatric Educators sessions that explored how research and teaching intersect in practice, including discussions on the effectiveness of case-based teaching, pathways in medical education and the value of embracing failure as a driver of growth in academic medicine. Beyond the lecture halls, community engagement remained central, with a Safe Kids Worldwide event on Friday focused on fostering safety education and training for children and families. Supported by executive sponsors Nathan Kuppermann, MD, MPH; Catherine Bollard, MBChB, MD; Stella Ghattas, Esq; Elizabeth Wells, MD; and Cicely (CC) Brooks, DNP-ENL, MSN, RN, NE-BC, FAB, Children’s National continues to build the conditions where that kind of science can thrive.

REI Week 2027 takes place the week of April 5, and what happens between now and then matters just as much as what happens during that week. Every study advanced, every collaboration forged and every trainee who finds their footing in this community is part of the same long effort to reimagine what pediatric health can look like. That work doesn’t happen without investment in people, in ideas and in the infrastructure that turns discovery into care. If this week moved you, consider supporting what comes next.

Expanding naloxone access could reduce adolescent overdose deaths

bottle of narcan

Naloxone, an opioid antagonist available as a nasal spray, rapidly reverses overdose by blocking opioid receptors.

Opioid-related deaths continue to remain high among adolescents. Naloxone, an opioid antagonist available as a nasal spray, rapidly reverses overdose by blocking opioid receptors. The medication is easy to administer, has minimal side effects and produces no effect if opioids are not present. Despite these advantages, naloxone is often not used even when another person is present during an adolescent’s overdose event.

In a recent clinical perspective in JAACAP Connect, researchers recommend that clinicians prescribe naloxone more broadly to adolescents and advocate for fewer restrictions on carrying the medication in schools and communities.

“Naloxone is a lifesaving intervention with minimal risk, yet many adolescents who could benefit from it do not have timely access,” said Sivabalaji Kaliamurthy, MD, director of the Addictions Program at Children’s National Hospital and lead author of the article. “Expanding prescribing practices and reducing stigma around naloxone are critical steps in preventing avoidable overdose deaths.”

The hold-up in the field

Several barriers continue to limit naloxone access for adolescents. Some school policies restrict students from carrying the medication, instead storing it in nurses’ offices, which may delay response during emergencies that occur outside the classroom or off campus. Stigma also remains a concern, with some administrators and community members believing that providing naloxone encourages substance use.

Confidentiality and consent laws can create additional challenges. Because regulations governing adolescent consent for substance use treatment vary by state, prescribing naloxone may sometimes require parental involvement, which can discourage youth from seeking care.

Moving toward solutions

The authors emphasize that evidence does not support the idea that increased naloxone availability leads to increased drug use. Studies examining expanded naloxone access laws have not found meaningful increases in heroin or injection drug use, suggesting that broader distribution can improve safety without worsening substance use.

To improve access, clinicians can screen adolescents routinely for overdose risk factors, prescribe naloxone more broadly and educate families and school personnel about the medication’s safety. Writing notes that allow students to self-carry naloxone, connecting patients with community distribution programs and advocating for clearer school and state policies may also help reduce barriers.

With overdose deaths continuing to be high among adolescents, the authors conclude that improving naloxone access is a practical and evidence-based way to reduce preventable fatalities.

Additional Children’s National authors include Laura Willing, MD.

Read the full clinical perspective, Prescribing Nasal Naloxone in Pediatrics: A Clinical Perspective on Reducing Overdose Deaths, in JAACAP Connect.

Dr. Nathan Kuppermann honored by AAAS for leadership in pediatric research

Nathan Kuppermann

Dr. Kuppermann was recognized for his leadership in pediatric emergency care and for research that has helped shape how clinicians diagnose, treat and prevent life-threatening illness and injury in children.

Nathan Kuppermann, MD, MPH, executive vice president, chief academic officer and chair of Pediatrics at Children’s National Hospital, and director of the Children’s National Research Institute has been elected as a Fellow of the American Association for the Advancement of Science (AAAS), one of the world’s largest and most prestigious scientific societies. Election as an AAAS Fellow is among the highest honors in science, recognizing individuals whose contributions have advanced research, innovation and its application for the benefit of society.

Dr. Kuppermann was recognized for his leadership in pediatric emergency care and for research that has helped shape how clinicians diagnose, treat and prevent life-threatening illness and injury in children. His work spans infectious diseases, trauma and neurologic complications of diabetic ketoacidosis, as well as the development of large, multi-center research networks that have transformed how pediatric studies are conducted in the United States and around the world.

“Advancing pediatric research has always been a team effort,” said Dr. Kuppermann. “This honor reflects the extraordinary colleagues, collaborators and trainees I’ve had the privilege to work with, and the shared commitment we have to improving care for children around the world through rigorous science.”

Founded in 1848, AAAS elects Fellows each year whose work is considered scientifically or socially distinguished. The tradition dates back to 1874, and Fellows include some of the most influential researchers, physicians and innovators across disciplines.

At Children’s National, Dr. Kuppermann leads the academic enterprise spanning clinical care, research and education. His career has focused on building the infrastructure needed to answer complex pediatric questions through collaboration, including national and international research networks that allow investigators to study rare conditions, test new treatments and generate evidence that directly informs clinical practice.

His election as an AAAS Fellow reflects not only his individual contributions, but also the growing impact of pediatric research conducted at Children’s National and across its academic and innovation ecosystem.

As pediatric medicine becomes increasingly data-driven and collaborative, leaders like Kuppermann are helping define how research moves from discovery to real-world impact, ensuring that children benefit from the same level of scientific progress seen in adult medicine, while addressing the unique challenges of studying specialized pediatric populations.